(VIANEWS) – The NASDAQ ended the session with Xenetic Biosciences (XBIO) rising 8.16% to $0.66 on Saturday while NASDAQ rose 3.82% to $11,805.00.
Volume
Today’s last reported volume for Xenetic Biosciences is 71604, 65.69% below its average volume of 208753.
Xenetic Biosciences’s last close was $0.62, 89.08% below its 52-week high of $5.68.
Xenetic Biosciences’s Sales
Xenetic Biosciences’s sales growth is 72.4% for the current quarter and a decline by 33.8% for the next. The company’s growth estimates for the present quarter and the next is 90% and 6.3%, respectively.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Xenetic Biosciences’s stock is considered to be overbought (>=80).
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $0.66 at 00:35 EST, way below its 52-week low of $1.21.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s worth is way under its 50-day moving average of $1.64 and way below its 200-day moving average of $2.19.
More news about Xenetic Biosciences (XBIO).
